NCT00617747View on ClinicalTrials.gov

Efficacy and Tolerability of Zolmitriptan Nasal Spray

PHASE3CompletedINTERVENTIONAL
Enrollment

2,114

Participants

Timeline

Start Date

September 30, 2002

Study Completion Date

June 30, 2003

Conditions
Migraine
Interventions
DRUG

Zolmitriptan

5mg Nasal Spray

DRUG

Placebo

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY